Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 2;25(7):e202300819.
doi: 10.1002/cbic.202300819. Epub 2024 Mar 5.

Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)-[11C]YH132: Application in Drug Development and Neurodegenerative Diseases

Yingfang He  1   2 , Aro Delparente  1 , Caitlin V M L Jie  1 , Claudia Keller  1 , Roland Humm  3 , Dominik Heer  3 , Ludovic Collin  3 , Roger Schibli  1 , Luca Gobbi  3 , Uwe Grether  3 , Linjing Mu  1
Affiliations

Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)-[11C]YH132: Application in Drug Development and Neurodegenerative Diseases

Yingfang He et al. Chembiochem. .

Abstract

Monoacylglycerol lipase (MAGL) plays a crucial role in the degradation of 2-arachidonoylglycerol (2-AG), one of the major endocannabinoids in the brain. Inhibiting MAGL could lead to increased levels of 2-AG, which showed beneficial effects on pain management, anxiety, inflammation, and neuroprotection. In the current study, we report the characterization of an enantiomerically pure (R)-[11C]YH132 as a novel MAGL PET tracer. It demonstrates an improved pharmacokinetic profile compared to its racemate. High in vitro MAGL specificity of (R)-[11C]YH132 was confirmed by autoradiography studies using mouse and rat brain sections. In vivo, (R)-[11C]YH132 displayed a high brain penetration, and high specificity and selectivity toward MAGL by dynamic PET imaging using MAGL knockout and wild-type mice. Pretreatment with a MAGL drug candidate revealed a dose-dependent reduction of (R)-[11C]YH132 accumulation in WT mouse brains. This result validates its utility as a PET probe to assist drug development. Moreover, its potential application in neurodegenerative diseases was explored by in vitro autoradiography using brain sections from animal models of Alzheimer's disease and Parkinson's disease.

Keywords: PET imaging; in vitro autoradiography; monoacylglycerol lipase.

PubMed Disclaimer

References

    1. O. Aizpurua-Olaizola, I. Elezgarai, I. Rico-Barrio, I. Zarandona, N. Etxebarria, A. Usobiaga, Drug Discovery Today 2017, 22 (1), 105–110.
    1. M. Maccarrone, V. Marzo, J. Gertsch, U. Grether, A. C. Howlett, T. Hua, A. Makriyannis, D. Piomelli, N. Ueda, M. van der Stelt, Pharmacol Rev. 2023, 75, 885–958 .
    1. J. R. Savinainen, S. M. Saario, J. T. Laitinen, Acta Physiol. 2012, 204 (2), 267–276.
    1. J. L. Blankman, G. M. Simon, B. F. Cravatt, Chem. Biol. 2007, 14 (12), 1347–1356.
    1. D. K. Nomura, B. E. Morrison, J. L. Blankman, J. Z. Long, S. G. Kinsey, M. C. G. Marcondes, A. M. Ward, Y. K. Hahn, A. H. Lichtman, B. Conti, et al., Science 2011, 334 (6057), 809–813.

Publication types

LinkOut - more resources